DRAK1 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP7220a
Background:
DRAK1 is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain. The protein has apoptosis-inducing activity.
Other Names:
Serine/threonine-protein kinase 17A, DAP kinase-related apoptosis-inducing protein kinase 1, STK17A, DRAK1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7220a was selected from the N-term region of human DRAK1 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: STK17A
Gene ID: 9263
Primary Accession: Q9UEE5
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
DRAK1 is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain. The protein has apoptosis-inducing activity.
Other Names:
Serine/threonine-protein kinase 17A, DAP kinase-related apoptosis-inducing protein kinase 1, STK17A, DRAK1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7220a was selected from the N-term region of human DRAK1 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: STK17A
Gene ID: 9263
Primary Accession: Q9UEE5
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review